340B Community Mourns Loss of Longtime Health Center and 340B Advocate and Educator Sue Veer

The late Sue Veer was remembered this week by colleagues and friends as a leader, educator, mentor, friend and tireless advocate for health centers and the 340B program. (Photo courtesy of NACHC).
The 340B community is mourning the recent passing of Sue Veer, a nationally recognized leader for community health centers and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

An Emerging Threat to Your 340B Program: DSH Percentage Reductions

SPONSORED CONTENT

The 340B program has been bombarded with threats over the past five years. 340B professionals have had their hands full defending the safety net program from contract pharmacy restrictions, state-level reporting, proposed legislative changes, the IRA, rebate models, and

Read More »
Industry Insights Logo

Is Your 340B Partner a Good Fit? Look for These Signs

SPONSORED CONTENT

Whether it’s new manufacturer restrictions affecting script and data qualification, amended state laws or regulations, or updated audit guidelines, the 340B landscape is constantly evolving. So, it’s no surprise that managing an organization’s 340B program is not easy

Read More »

Six Drugmakers to Refund 340B Covered Entities for Overcharges

Six drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025.
Several drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025, following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly Looks to Align U.S. Drug Prices with Other Nations Under Trump’s MFN Plan, Cites 340B ‘Abuse’ as Factor in Higher Costs 

Eli Lilly recently announced it’s working on certain pharmaceutical pricing changes to comply with President Donald Trump’s "most-favored nation" executive order.
An Indiana-based pharmaceutical giant recently announced that it’s working to align its U.S. drug prices with those paid by other [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Anti-340B Dark Money Group Promotes GOP-Passed Reconciliation Bill in New Ad

Dark money group Building America’s Future released a 30-second ad touting the new reconciliation budget law, which includes massive Medicaid spending cuts.
The dark money group behind a campaign targeting GOP-led states’ efforts to enact 340B contract pharmacy access laws recently released [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital and Pharmacist Groups ask HRSA to Extend 340B Rebate Model Pilot Proposal Timeline

Hospital and pharmacist trade groups asked HRSA Administrator Thomas Engels in an Aug. 8 letter to extend the rebate model pilot proposal's deadlines.
Trade groups representing 340B hospitals and hospital pharmacists recently urged the Health Resources and Services Administration (HRSA) to extend the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Commonwealth Fund Explainer Highlights Key Issues Surrounding 340B Program and Potential Reforms

An Aug. 6 Commonwealth Fund explainer looked at the state of the 340B program and potential reforms.
A prestigious health care think tank recently offered an overview of the 340B program—including criticisms surrounding its growth and drugmakers’ [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

FQHCs Face Unique Challenges—Strong Partnerships Can Make All the Difference

SPONSORED CONTENT

Federally Qualified Health Centers (FQHCs) play a critical role in delivering accessible and affordable healthcare to underserved communities. However, they are facing mounting challenges that threaten their ability to maintain operations and meet growing community needs. With limited infrastructure, evolving regulations, upcoming Medicaid cuts, drops in the insured

Read More »

Sobi, J&J Exempt New States from 340B Contract Pharmacy Restrictions

Drugmakers Sobi and Johnson & Johnson recently announced additional 340B contract pharmacy restriction exemptions for states that have enacted new contract pharmacy access laws.
Two major drugmakers recently announced additional 340B contract pharmacy restriction exemptions for states that have enacted new contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live